This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horikawa, Y. Articles by Kasuga, M. Search for Related Content PubMed PubMed Citation Articles by Horikawa, Y. Articles by Kasuga, M. Related Collections Diabetes and Insulin

Replication of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan

Department of Diabetes and Endocrinology (Y.Ho., M.E., J.T.), Division of Molecule and Structure, Gifu University School of Medicine, Gifu 501-1194, Japan; Laboratory of Medical Genomics (Y.Ho.), Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8512, Japan; Division of Diabetes, Metabolism and Endocrinology (K.M., Y.Hir., M.K.), Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan; Department of Metabolic Disorder (K.Yas.), Research Institute, International Medical Center of Japan, Tokyo 162-8655, Japan; Department of Metabolic Medicine (K.Yamag.), Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; Division of Molecular Metabolism and Diabetes (Y.Hin., Y.O.), Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Department of Medicine (N.I., Y.I.), Diabetes Center, Tokyo Women’s Medical University, Tokyo 162-8666, Japan; Department of Diabetes and Clinical Nutrition (Y.Y., Y.S.), Kyoto University School of Medicine, Kyoto 606-8501, Japan; Division of Endocrinology and Metabolism Department of Medicine (H.M., A.K.), Shiga University of Medical Science, Shiga 520-2192, Japan; Department of Molecular Genetics (K.Yamam.), Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan; and Department of Human Genetics (K.T.), Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan

Address all correspondence and requests for reprints to: Masato Kasuga, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. E-mail: kasuga{at}med.kobe-u.ac.jp.

Background: In Europeans and populations of European origin, several groups have recently identified novel type 2 diabetes susceptibility genes, including FTO, SLC30A8, HHEX, CDKAL1, CDKN2B, and IGF2BP2, none of which were in the list of functional candidates.

Objective and Design: The aim of this study was to replicate in a Japanese population previously identified associations of single nucleotide polymorphisms (SNPs) within 10 candidate loci with type 2 diabetes using a relatively large sample size: 1921 subjects with type 2 diabetes and 1622 normal controls.

Results: A total of 15 SNPs were genotyped. Eight SNPs in five loci were found to be associated with type 2 diabetes: rs3802177 [odds ratio (OR) = 1.16 (95% confidence interval (CI) 1.05–1.27); P = 4.5 x 10^–3] in SLC30A8; rs1111875 [OR = 1.27 (95% CI 1.14–1.40); P = 1.4 x 10^–5] and rs7923837 [OR = 1.27 (95% CI 1.13–1.43); P = 1.0 x 10^–4] in HHEX; rs10811661 [OR = 1.27 (95% CI 1.15–1.40); P = 1.9 x 10^–6] in CDKN2B; rs4402960 [OR = 1.23 (95% CI 1.11–1.36); P = 8.1 x 10^–5] and rs1470579 [OR = 1.18 (95% CI 1.07–1.31); P = 8.3 x 10^–4] in IGF2BP2; and rs7754840 [OR = 1.28 (95% CI 1.17–1.41); P = 4.5 x 10^–7] and rs7756992 [OR = 1.27 (95% CI 1.15–1.40); P = 9.8 x 10^–7] in CDKAL1. The first and second strongest associations were found at variants in CDKAL1 and CDKN2B, both of which are involved in the regenerative capacity of pancreatic β-cells.

Conclusion: Some of these variants represent common type 2 diabetes-susceptibility genes in both Japanese and Europeans.

This article has been cited by other articles:

				J. Christiansen, A. M Kolte, T. v O Hansen, and F. C Nielsen IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes J. Mol. Endocrinol., November 1, 2009; 43(5): 187 - 195. [Abstract] [Full Text] [PDF]

				H. Staiger, F. Machicao, A. Fritsche, and H.-U. Haring Pathomechanisms of Type 2 Diabetes Genes Endocr. Rev., October 1, 2009; 30(6): 557 - 585. [Abstract] [Full Text] [PDF]

				F. Takeuchi, M. Serizawa, K. Yamamoto, T. Fujisawa, E. Nakashima, K. Ohnaka, H. Ikegami, T. Sugiyama, T. Katsuya, M. Miyagishi, et al. Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population Diabetes, July 1, 2009; 58(7): 1690 - 1699. [Abstract] [Full Text] [PDF]

				C. H.T. Tam, R. C.W. Ma, W. Y. So, Y. Wang, V. K.L. Lam, S. Germer, M. Martin, J. C.N. Chan, and M. C.Y. Ng Interaction Effect of Genetic Polymorphisms in Glucokinase (GCK) and Glucokinase Regulatory Protein (GCKR) on Metabolic Traits in Healthy Chinese Adults and Adolescents Diabetes, March 1, 2009; 58(3): 765 - 769. [Abstract] [Full Text] [PDF]

				Y. Tabara, H. Osawa, R. Kawamoto, H. Onuma, I. Shimizu, T. Miki, K. Kohara, and H. Makino Replication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening Diabetes, February 1, 2009; 58(2): 493 - 498. [Abstract] [Full Text] [PDF]